For example, in retinoblastoma, PRMT5 promotes VEGF transcription by enhancing H3K4me3 at its promoter, and in gliomas, it cooperates with HOXC10 and WDR5 to upregulate VEGF expression [362, 363]. Here, VEGFA is linked to central nervous system cancer.